None
RO
<![CDATA[Your Product Is Ready. Your Launch Strategy Isn't]]>
[]
Pharmaceutical Executive articles
Even products with a competitive advantage underperform three-year consensus targets 29% of the time; product superiority alone correlates with 49% overperformance.
A behavioral study of 690 adoption decision makers reveals why.
They cite product attributes as their top driver, but behavior shows that product explains roughly 15% of adoption behavior.
One approach is the ZS Launch Commitment Signal, a diagnostic index for launch strategy, much like Net Promoter Score (NPS) for customer loyalty.
A winning launch strategy starts with one question: Is our organization committed to the depth, speed, and credibility this market requires?